학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 317건 | 목록 1~20
Academic Journal
Bancroft EK; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Page EC; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; McHugh J; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Thomas S; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Taylor N; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Pope J; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Evans DG; Department of Genomic Medicine, Division of Evolution, Infection and Genomic Sciences, University of Manchester, Manchester, UK.; Rothwell J; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.; Grindedal EM; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.; Maehle L; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.; James P; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Genetic Medicine, Royal Melbourne Hospital, Parkville, Australia.; McKinley J; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Mascarenhas L; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Side L; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.; Thomas T; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.; van Leerdam ME; Dutch Foundation for Detection of Hereditary Tumors, Leiden, The Netherlands; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.; van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Kiemeney LALM; Radboud University Medical Center, Nijmegen, The Netherlands.; Ringelberg J; Dutch Foundation for Detection of Hereditary Tumors, Leiden, The Netherlands.; Vlaming M; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.; Rønlund K; Department of Clinical Genetics, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Osther PJS; Department of Urology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Helfand BT; John and Carol Walter Center for Urological Health, Division of Urology, Endeavor Health NorthShore University HealthSystem, Evanston, IL, USA.; Hutten CG; Internal Medicine Epidemiology, Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, USA.; Oldenburg RA; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cybulski C; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.; Wokolorczyk D; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.; Ong KR; Department of Clinical Genetics, Birmingham Women's Hospital, Birmingham, UK.; Huber C; Department of Clinical Genetics, Birmingham Women's Hospital, Birmingham, UK.; Salinas M; Hereditary Cancer Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.; Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.; Oosterwijk JC; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; van Zelst-Stams WAG; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.; Cook J; Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.; Rosario DJ; Royal Hallamshire Hospital, Sheffield, UK.; Maxwell K; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA.; Powers J; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA.; Buys S; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Lyman J; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Ausems MGEM; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.; Schmutzler RK; Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Rhiem K; Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Izatt L; Clinical Genetics Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK.; Tripathi V; Clinical Genetics Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK.; Teixeira MR; Department of Laboratory Genetics and IPO Porto Research Center, Portuguese Oncology Institute (IPO Porto), Porto, Portugal; School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.; Cardoso M; Department of Laboratory Genetics and IPO Porto Research Center, Portuguese Oncology Institute (IPO Porto), Porto, Portugal.; Foulkes WD; Cancer Research Program, Research Institute of McGill University Health Centre, Montreal, Canada; Lady Davis Institute and Division of Medical Genetics, Jewish General Hospital, McGill University, Montreal, Canada.; Aprikian A; Cancer Research Program, Research Institute of McGill University Health Centre, Montreal, Canada; Departments of Surgery and Oncology, McGill University, Montreal, Canada.; Davidson R; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK.; Longmuir M; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK.; Ruijs MWG; Department of Clinical Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Blom EW; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.; van Engelen K; Department of Human Genetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Williams R; School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, Australia; Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, Australia.; Andrews L; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia; Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, Australia.; Murphy DG; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; Saya S; Department of General Practice and Primary Care, University of Melbourne, Melbourne, Australia.; Halliday D; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; Walker L; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; Liljegren A; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.; Carlsson S; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.; Azzabi A; Northern Genetics Service, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK.; Jobson I; Northern Genetics Service, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK.; Snape K; St. George's Hospital, London, UK.; Gowie M; St. George's Hospital, London, UK.; Harris M; Familial Cancer Centre, Monash Health, Clayton, Australia.; Tischkowitz M; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK; Department of Genomic Medicine, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.; Taylor A; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK.; Kirk J; Familial Cancer Service, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.; Susman R; Genetic Health Queensland, Royal Brisbane & Women's Hospital, Herston, Australia.; Chen-Shtoyerman R; The Adelson School of Medicine and Department of Molecular Biology, Ariel University, Ariel, Israel; The Genetic Institute, Kaplan Medical Center, Rehovot, Israel.; Spigelman A; Hunter Family Cancer Service, Waratah, Australia; St. Vincent's Clinical School, University of New South Wales, Sydney, Australia; Cancer Genetics Clinic, The Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia.; Pachter N; Genetic Services of Western Australia, King Edward Memorial Hospital, Subiaco, Australia; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.; Ahmed M; North East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.; Cajal TRY; Hospital de Sant Pau, Barcelona, Spain.; Krajc M; Institute of Oncology, Ljubljana, Slovenia.; Cleaver R; Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK.; Cruellas M; Hereditary Cancer Genetics Group, Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Medical Oncology Department, Hospital Clínico Univesitario Lozano Blesa, Zaragoza, Spain.; Perez-Ballestero E; Hereditary Cancer Genetics Group, Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Brady AF; North West Thames Regional Genetics Service, Northwick Park Hospital, London North West University Healthcare NHS Trust, Harrow, UK.; Gallagher D; St. James's Hospital, Dublin, Ireland.; Donaldson A; St. Michael's Hospital, Bristol, UK.; Barwell J; University of Leicester, Leicester, UK; University Hospitals Leicester, Leicester, UK.; Nicolai N; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Friedman E; Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Hall MJ; Fox Chase Cancer Center, Philadelphia, PA, USA.; Greenhalgh L; Clinical Genetics Service, Liverpool Women's Hospital, Liverpool, UK.; Murthy V; Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.; Copakova L; National Cancer Institute, Bratislava, Slovakia.; McGrath JS; North Bristol NHS Trust, Bristol, UK; University of Exeter Medical School, Exeter, UK.; Cooke P; New Cross Hospital, Wolverhampton, UK.; Arun B; MD Anderson Cancer Center, University of Texas, Houston, TX, USA.; Myhill K; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Hogben M; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Hussain S; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Aaronson NK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Ardern-Jones A; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Bangma CH; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Castro E; Hospital Universitario 12 de Octubre, Madrid, Spain.; Dearnaley D; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Eccles DM; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK; Cancer Sciences, The University of Southampton, Southampton, UK.; Tricker K; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.; Falconer A; Imperial College Healthcare NHS Trust, London, UK.; Gronberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Hamdy FC; Churchill Hospital, Oxford, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.; Khoo V; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK; St. George's Hospital, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Medicine, The University of Melbourne, Parkville, Australia.; Lilja H; Department of Translational Medicine, Lund University, Malmö, Sweden; Departments of Pathology and Laboratory Medicine, Surgery and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Lindeman GJ; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; Department of Medicine, The University of Melbourne, Parkville, Australia; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.; Axcrona K; Department of Urology, Akershus University Hospital, Lørenskog, Norway.; Mikropoulos C; Royal Surrey Hospital, Guildford, UK.; Mitra A; University College London Hospitals NHS Foundation Trust, London, UK.; Offman J; Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University, London, UK.; Rennert G; Technion-Israel Institute of Technology, Haifa, Israel.; Suri M; Nottingham City Hospital, Nottingham, UK.; Dudderidge T; University Hospital Southampton, Southampton, UK.; Brook MN; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Kote-Jarai Z; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Eeles RA; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: ros.eeles@icr.ac.uk.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Christopher HakkaartJohn F. PearsonLouise MarquartJoe DennisGeorge A. R. WigginsDaniel R. BarnesBridget A. RobinsonPeter D. MaceKristiina AittomäkiIrene L. AndrulisBanu K. ArunJacopo AzzolliniJudith BalmañaRosa B. BarkardottirSami BelhadjLieke BergerMarinus J. BlokSusanne E. BoonenJulika BordeAngela R. BradburyJoan BrunetSaundra S. BuysMaria A. CaligoIan CampbellWendy K. ChungKathleen B. M. ClaesGEMO Study CollaboratorsEMBRACE CollaboratorsMarie-Agnès Collonge-RameJackie CookCasey CosgroveFergus J. CouchMary B. DalySita DandikerRosemarie DavidsonMiguel de la HoyaRobin de PutterCapucine DelnatteMallika DhawanOrland DiezYuan Chun DingSusan M. DomchekAlan DonaldsonJacqueline EasonDouglas F. EastonHans EhrencronaChristoph EngelD. Gareth EvansUlrike FaustLidia FeliubadalóFlorentia FostiraEitan FriedmanMegan FroneDebra FrostJudy GarberSimon A. GaytherAndrea GehrigPaul GestaAndrew K. GodwinDavid E. GoldgarMark H. GreeneEric HahnenChristopher R. HakeUte HamannThomas V. O. HansenJan HaukeJulia HentschelNatalie HeroldEllen HonischPeter J. HulickEvgeny N. ImyanitovSWE-BRCA InvestigatorskConFab InvestigatorsHEBON InvestigatorsClaudine IsaacsLouise IzattAngel IzquierdoAnna JakubowskaPaul A. JamesRamunas JanaviciusEsther M. JohnVijai JosephBeth Y. KarlanZoe KempJudy KirkIrene KonstantopoulouMarco KoudijsAva KwongYael LaitmanFiona LallooChristine LassetCharlotte LautrupConxi LazaroClémentine LegrandGoska LeslieFabienne LesueurPhuong L. MaiSiranoush ManoukianVéronique MariJohn W. M. MartensLesley McGuffogNoura MebiroukAlfons MeindlAustin MillerMarco MontagnaLidia MoserleEmmanuelle Mouret-FourmeHannah MusgraveSophie NambotKatherine L. NathansonSusan L. NeuhausenHeli NevanlinnaJoanne Ngeow Yuen YieTu Nguyen-DumontLiene Nikitina-ZakeKenneth OffitEdith OlahOlufunmilayo I. OlopadeAna OsorioClaus-Eric OttSue K. ParkMichael T. ParsonsInge Sokilde PedersenAna PeixotoPedro Perez-SeguraPaolo PeterlongoTimea PoczaPaolo RadiceJuliane RamserJohanna RantalaGustavo C. RodriguezKarina RønlundEfraim H. RosenbergMaria RossingRita K. SchmutzlerPayal D. ShahSaba SharifPriyanka SharmaLucy E. SideJacques SimardChristian F. SingerKatie SnapeDoris SteinemannDominique Stoppa-LyonnetChristian SutterYen Yen TanManuel R. TeixeiraSoo Hwang TeoMads ThomassenDarcy L. ThullMarc TischkowitzAmanda E. TolandAlison H. TrainerVishakha TripathiNadine TungKlaartje van EngelenElizabeth J. van RensburgAna VegaAlessandra VielLisa WalkerJeffrey N. WeitzelMarike R. WeversGeorgia Chenevix-TrenchAmanda B. SpurdleAntonis C. AntoniouLogan C. Walker
Communications Biology, Vol 5, Iss 1, Pp 1-15 (2022)
Academic Journal
Page, ECBancroft, EKBrook, MNAssel, MHassan Al Battat, MThomas, STaylor, NChamberlain, APope, JRaghallaigh, HNEvans, DGRothwell, JMaehle, LGrindedal, EMJames, PMascarenhas, LMcKinley, JSide, LThomas, Tvan Asperen, CVasen, HKiemeney, LARingelberg, JJensen, TDOsther, PJSHelfand, BTGenova, EOldenburg, RACybulski, CWokolorczyk, DOng, K-RHuber, CLam, JTaylor, LSalinas, MFeliubadaló, LOosterwijk, JCvan Zelst-Stams, WCook, JRosario, DJDomchek, SPowers, JBuys, SO'Toole, KAusems, MGEMSchmutzler, RKRhiem, KIzatt, LTripathi, VTeixeira, MRCardoso, MFoulkes, WDAprikian, Avan Randeraad, HDavidson, RLongmuir, MRuijs, MWGHelderman van den Enden, ATJMAdank, MWilliams, RAndrews, LMurphy, DGHalliday, DWalker, LLiljegren, ACarlsson, SAzzabi, AJobson, IMorton, CShackleton, KSnape, KHanson, HHarris, MTischkowitz, MTaylor, AKirk, JSusman, RChen-Shtoyerman, RSpigelman, APachter, NAhmed, MRamon Y Cajal, TZgajnar, JBrewer, CGadea, NBrady, AFvan Os, TGallagher, DJohannsson, ODonaldson, ABarwell, JNicolai, NFriedman, EObeid, EGreenhalgh, LMurthy, VCopakova, LSaya, SMcGrath, JCooke, PRønlund, KRichardson, KHenderson, ATeo, SHArun, BKast, KDias, AAaronson, NKArdern-Jones, ABangma, CHCastro, EDearnaley, DEccles, DMTricker, KEyfjord, JFalconer, AFoster, CGronberg, HHamdy, FCStefansdottir, VKhoo, VLindeman, GJLubinski, JAxcrona, KMikropoulos, CMitra, AMoynihan, CRennert, GSuri, MWilson, PDudderidge, TIMPACT Study CollaboratorsOffman, JKote-Jarai, ZVickers, ALilja, HEeles, RA
Eur Urol
EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
Universidad de Barcelona
The IMPACT Study Collaborators 2019, 'Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers', European Urology, vol. 76, no. 6, pp. 831-842. https://doi.org/10.1016/j.eururo.2019.08.019
European Urology, 76, 6, pp. 831-842
Page, E C, Bancroft, E K, Brook, M N, Assel, M, Hassan Al Battat, M, Thomas, S, Taylor, N, Chamberlain, A, Pope, J, Raghallaigh, H N, Evans, D G, Rothwell, J, Maehle, L, Grindedal, E M, James, P, Mascarenhas, L, McKinley, J, Side, L, Thomas, T, van Asperen, C, Vasen, H, Kiemeney, L A, Ringelberg, J, Jensen, T D, Osther, P J S, Helfand, B T, Genova, E, Oldenburg, R A, Cybulski, C, Wokolorczyk, D, Ong, K-R, Huber, C, Lam, J, Taylor, L, Salinas, M, Feliubadaló, L, Oosterwijk, J C, van Zelst-Stams, W, Cook, J, Rosario, D J, Domchek, S, Powers, J, Buys, S, O'Toole, K, Ausems, M G E M, Schmutzler, R K, Rhiem, K, Izatt, L, Johannsson, O, Rønlund, K & IMPACT Collaborators 2019, ' Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers ', European Urology, vol. 76, no. 6, pp. 831-842 . https://doi.org/10.1016/j.eururo.2019.08.019
IMPACT study collaborators 2019, 'Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers', European Urology. https://doi.org/10.1016/j.eururo.2019.08.019
Academic Journal
Antolí A; Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; The Systemic, Vascular Diseases and Ageing Group. Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Clinical Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Vargas-Parra G; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Sierra-Fortuny A; Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; The Systemic, Vascular Diseases and Ageing Group. Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Gomez-Vazquez JL; Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; The Systemic, Vascular Diseases and Ageing Group. Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Clinical Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Rofes P; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Munté E; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Viana-Errasti J; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Marín-Montes R; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.; López-Doriga A; Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.; Nennisiwok AI Lab, Barcelona, Spain.; Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Del Valle J; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Pérez-González A; Internal Medicine Department, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Pontevedra, Spain.; Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Pontevedra, Spain.; Poveda E; Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Pontevedra, Spain.; Solanich X; Internal Medicine Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; The Systemic, Vascular Diseases and Ageing Group. Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Clinical Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Lázaro C; Clinical Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. clazaro@iconcologia.net.; Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain. clazaro@iconcologia.net.; Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. clazaro@iconcologia.net.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. clazaro@iconcologia.net.
Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE
Academic Journal
Fortuno, CristinaFeng, Bing-JianCarroll, CourtneyInnella, GiovanniKohlmann, WendyLázaro, ConxiBrunet, JoanFeliubadaló, LidiaIglesias, SilviaMenéndez, MireiaTeulé, AlexBallinger, Mandy L.Thomas, David M.Campbell, AinsleyField, MikeHarris, MarionKirk, JudyPachter, NicholasPoplawski, NicolaSusman, RachelTucker, KathyWallis, MathewWilliams, RachelCops, ElisaGoldgar, DavidJames, Paul A.Spurdle, Amanda B.Amor, DavidAndrews, LesleyAntill, YolandBalleine, RosemaryBeesley, JonathanBennett, IanBogwitz, MichaelBodek, SimonBotes, LeonBrennan, MeaganBrown, MelissaBuckley, MichaelBurke, JoButow, PhyllisCaldon, LizCampbell, IanCao, MichelleChakrabarti, AnannyaChauhan, DeepaChauhan, ManishaChenevix-Trench, GeorgiaChristian, AliceCohen, PaulColley, AlisonCrook, AshleyCui, JamesCourtney, ElizaCummings, MargaretDawson, Sarah-JanedeFazio, AnnaDelatycki, MartinDickson, RebeccaDixon, JoanneEdkins, TedEdwards, StaceyFarshid, GelarehFellows, AndrewFenton, GeorginaField, MichaelFlanagan, JamesFong, PeterForrest, LauraFox, StephenFrench, JulietFriedlander, MichaelGaff, ClaraGattas, MikeGeorge, PeterGreening, SianHarris, MarionHart, StewartHayward, NickHopper, JohnHoskins, CassHunt, ClareJames, PaulJenkins, MarkKidd, AlexaKirk, JudyKoehler, JessicaKollias, JamesLakhani, SunilLawrence, MitchellLee, JasonLi, ShuaiLindeman, GeoffLippey, JocelynLipton, LaraLobb, LizLoi, ShereneMann, GrahamMarsh, DeborahMcLachlan, Sue AnneMeiser, BettinaMilne, RogerNightingale, SophieOʼConnell, ShonaOʼSullivan, SarahOrtega, David GallegoPachter, NickPang, Jia-MinPathak, GargiPatterson, BrionyPearn, AmyPhillips, KellyPieper, EllenRamus, SusanRickard, EdwinaRobinson, BridgetSaleh, MonaSkandarajah, AnitaSalisbury, ElizabethSaunders, ChristobelSaunus, JodiSavas, PeterScott, RodneyScott, ClareSexton, AdrienneShaw, JoanneShelling, AndrewSrinivasa, ShwetaSimpson, PeterSouthey, MelissaSpurdle, AmandaTaylor, JessicaTaylor, ReneaThorne, HeatherTrainer, AlisonTucker, KathyVisvader, JaneWalker, LoganWilliams, RachaelWinship, IngridYoung, Mary AnnZaheed, Milita
JCO Precision Oncology. Feb 01, 2024 8:e2300453-e2300453
Academic Journal
Lakeman, Inge M. M.van den Broek, Alexandra J.Vos, Juliën A. M.Barnes, Daniel R.Adlard, JulianAndrulis, Irene L.Arason, AdalgeirArnold, NorbertArun, Banu K.Balmaña, JudithBarrowdale, DanielBenitez, JavierBorg, AkeCaldés, TrinidadCaligo, Maria A.Chung, Wendy K.Claes, Kathleen B. M.Collée, J. MargrietCouch, Fergus J.Daly, Mary B.Dennis, JoeDhawan, MallikaDomchek, Susan M.Eeles, RosEngel, ChristophEvans, D. GarethFeliubadaló, LidiaForetova, LenkaFriedman, EitanFrost, DebraGanz, Patricia A.Garber, JudyGayther, Simon A.Gerdes, Anne-MarieGodwin, Andrew K.Goldgar, David E.Hahnen, EricHake, Christopher R.Hamann, UteHogervorst, Frans B. L.Hooning, Maartje J.Hopper, John L.Hulick, Peter J.Imyanitov, Evgeny N.Isaacs, ClaudineIzatt, LouiseJakubowska, AnnaJames, Paul A.Janavicius, RamunasJensen, Uffe BirkJiao, YueJohn, Esther M.Joseph, VijaiKarlan, Beth Y.Kets, Carolien M.Konstantopoulou, IreneKwong, AvaLegrand, ClémentineLeslie, GoskaLesueur, FabienneLoud, Jennifer T.Lubiński, JanManoukian, SiranoushMcGuffog, LesleyMiller, AustinGomes, Denise MolinaMontagna, MarcoMouret-Fourme, EmmanuelleNathanson, Katherine L.Neuhausen, Susan L.Nevanlinna, HeliYie, Joanne Ngeow YuenOlah, EdithOlopade, Olufunmilayo I.Park, Sue K.Parsons, Michael T.Peterlongo, PaoloPiedmonte, MarionRadice, PaoloRantala, JohannaRennert, GadRisch, Harvey A.Schmutzler, Rita K.Sharma, PriyankaSimard, JacquesSinger, Christian F.Stadler, ZsofiaStoppa-Lyonnet, DominiqueSutter, ChristianTan, Yen YenTeixeira, Manuel R.Teo, Soo HwangTeulé, AlexThomassen, MadsThull, Darcy L.Tischkowitz, MarcToland, Amanda E.Tung, Nadinevan Rensburg, Elizabeth J.Vega, AnaWappenschmidt, BarbaraDevilee, Peter van Asperen, Christi J.Bernstein, Jonine L.Offit, KennethEaston, Douglas F.Rookus, Matti A.Chenevix-Trench, GeorgiaAntoniou, Antonis C.Robson, MarkSchmidt, Marjanka K.
Genetics in Medicine: Official journal of the American College of Medical Genetics and Genomics. 23(9):1726-1737
Academic Journal
Blanco, IgnacioKuchenbaecker, KarolineCuadras, DanielWang, XianshuBarrowdale, Danielde Garibay, Gorka RuizLibrado, PabloSánchez-Gracia, AlejandroRozas, JulioBonifaci, NúriaMcGuffog, LesleyPankratz, Vernon SIslam, AbulMateo, FrancescaBerenguer, AntoniPetit, AnnaCatalà, IsabelBrunet, JoanFeliubadaló, LidiaTornero, EvaBenítez, JavierOsorio, AnaCajal, Teresa Ramón YNevanlinna, HeliAittomäki, KristiinaArun, Banu KToland, Amanda EKarlan, Beth YWalsh, ChristineLester, JennyGreene, Mark HMai, Phuong LNussbaum, Robert LAndrulis, Irene LDomchek, Susan MNathanson, Katherine LRebbeck, Timothy RBarkardottir, Rosa BJakubowska, AnnaLubinski, JanDurda, KatarzynaJaworska-Bieniek, KatarzynaClaes, KathleenVan Maerken, TomDíez, OrlandHansen, Thomas VJønson, LarsGerdes, Anne-MarieEjlertsen, Bentde la Hoya, MiguelCaldés, TrinidadDunning, Alison MOliver, ClareFineberg, ElenaCook, MargaretPeock, SusanMcCann, EmmaMurray, AlexJacobs, ChrisPichert, GabriellaLalloo, FionaChu, CarolDorkins, HuwPaterson, JoanOng, Kai-RenTeixeira, Manuel RHogervorst, Frans B Lvan der Hout, Annemarie HSeynaeve, Carolinevan der Luijt, Rob BLigtenberg, Marjolijn J LDevilee, PeterWijnen, Juul TRookus, Matti AMeijers-Heijboer, Hanne E JBlok, Marinus Jvan den Ouweland, Ans M WAalfs, Cora MRodriguez, Gustavo CPhillips, Kelly-Anne APiedmonte, MarionNerenstone, Stacy RBae-Jump, Victoria LO'Malley, David MRatner, Elena SSchmutzler, Rita KWappenschmidt, BarbaraRhiem, KerstinEngel, ChristophMeindl, AlfonsDitsch, NinaArnold, NorbertPlendl, Hansjoerg JNiederacher, DieterSutter, ChristianWang-Gohrke, ShanSteinemann, DorisPreisler-Adams, SabineKast, KarinVaron-Mateeva, RaymondaGehrig, AndreaBojesen, AndersPedersen, Inge SokildeSunde, LoneJensen, Uffe BirkThomassen, MadsKruse, Torben AForetova, LenkaPeterlongo, PaoloBernard, LorisPeissel, BernardScuvera, GiuliettaManoukian, SiranoushRadice, PaoloOttini, LauraMontagna, MarcoAgata, SimonaMaugard, ChristineSimard, JacquesSoucy, PennyBerger, AndreasFink-Retter, AnnelieseSinger, Christian FRappaport, ChristineGeschwantler-Kaulich, DaphneTea, Muy-KhengPfeiler, GeorgJohn, Esther MMiron, AlexNeuhausen, Susan LTerry, Mary BethChung, Wendy KDaly, Mary BGoldgar, David EJanavicius, RamunasDorfling, Cecilia Mvan Rensburg, Elisabeth JFostira, FlorentiaKonstantopoulou, IreneGarber, JudyGodwin, Andrew KOlah, EdithNarod, Steven ARennert, GadPaluch, Shani ShimonLaitman, YaelFriedman, EitanLiljegren, AnnelieRantala, JohannaStenmark Askmalm, MarieLoman, NiklasImyanitov, Evgeny NHamann, UteSpurdle, Amanda BHealey, SueWeitzel, Jeffrey NHerzog, JosefMargileth, DavidGorrini, ChiaraEsteller, ManelGómez, AntonioSayols, SergiVidal, EnriqueHeyn, HolgerStoppa-Lyonnet, DominiqueLéoné, MelanieBarjhoux, LaureFassy-Colcombet, Marionde Pauw, AntoineLasset, ChristineFerrer, Sandra FertCastera, LaurentBerthet, PascalineCornelis, FrançoisBignon, Yves-JeanDamiola, FrancescaMazoyer, SylvieSinilnikova, Olga MMaxwell, Christopher AVijai, JosephRobson, MarkKauff, NoahCorines, Marina JVillano, DanylkoCunningham, JulieLee, AdamLindor, NoralaneLázaro, ConxiEaston, Douglas FOffit, KennethChenevix-Trench, GeorgiaCouch, Fergus JAntoniou, Antonis CPujana, Miguel Angel
PLoS ONE. 10(4)
Academic Journal
Alvaro-Aranda L; Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.; Petitalot A; Department of Genetics, Institut Curie, Paris 75005, France.; PSL Research University, Paris 75005, France.; Djeghmoum Y; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Panigada D; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Singh JK; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Ehlén Å; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Vugic D; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Martin C; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Miron S; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France.; Contreras-Perez A; Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.; Nhiri N; Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France.; Boucherit V; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Lafitte P; Department of Genetics, Institut Curie, Paris 75005, France.; PSL Research University, Paris 75005, France.; Dumoulin I; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.; Quiles F; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Rouleau E; Department of Genetics, Institut Curie, Paris 75005, France.; PSL Research University, Paris 75005, France.; Jacquet E; Institut de Chimie des Substances Naturelles, Paris-Saclay University, CNRS, 91190 Gif-sur-Yvette, France.; Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Del Valle J; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Sharan SK; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, USA.; Stoppa-Lyonnet D; Department of Genetics, Institut Curie, Paris 75005, France.; Paris-Cité University, Paris, France.; INSERM U830, Institut Curie, Paris 75005, France.; Zinn-Justin S; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Paris-Saclay University, 91190 Gif-sur-Yvette, France.; Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.; Ciber Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Caputo SM; Department of Genetics, Institut Curie, Paris 75005, France.; PSL Research University, Paris 75005, France.; Carreira A; Genome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.; Institut Curie, PSL Research University, CNRS, UMR3348, F-91405 Orsay, France.; Paris-Saclay University CNRS, UMR3348, F-91405 Orsay, France.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE
Academic Journal
López-Fernández A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Duran-Lozano L; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Villacampa G; Oncology Data Science (ODysSey) Group, VHIO, Barcelona, Spain.; Pardo M; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Genetic Counseling Unit, Oncology Service, Hospital del Mar, Barcelona, Spain.; Pérez E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Darder E; Hereditary Cancer Program, Catalan Institute of Oncology, Josep Trueta University Hospital, IDIBGI, Girona, Spain.; Vallmajó A; Genetic Counseling Unit, Arnau de Vilanova University Hospital, Lleida, Spain.; Alfonso R; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Cruellas M; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Roqué A; Hereditary Cancer Program, Catalan Institute of Oncology, Josep Trueta University Hospital, IDIBGI, Girona, Spain.; Cartró M; Hereditary Cancer Unit, Corporació Sanitaria Parc Taulí, Sabadell, Spain.; Bareas A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Carrasco E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Rezqallah A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Jimenez-Macedo AR; Medical Oncology Service, Consorci Sanitari de Terrassa, Terrassa, Spain.; Torres-Esquius S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Torres M; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Lopez C; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Espinosa M; Breast Surgical Unit, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Teulé A; Hereditary Cancer Program, Catalan Institute of Oncology-ICO, ONCOBELL-IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Munté E; Hereditary Cancer Program, Catalan Institute of Oncology-ICO, ONCOBELL-IDIBELL, L'Hospitalet de Llobregat, Spain.; Tuset N; Genetic Counseling Unit, Arnau de Vilanova University Hospital, Lleida, Spain.; Diez O; Area of Clinical and Molecular Genetics, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology-ICO, ONCOBELL-IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology-ICO, ONCOBELL-IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Llort G; Hereditary Cancer Unit, Corporació Sanitaria Parc Taulí, Sabadell, Spain.; Medical Oncology Service, Consorci Sanitari de Terrassa, Terrassa, Spain.; Carver T; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Ficorella L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Mavaddat N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Mercadé A; Servei Veterinari de Genètica Molecular (SVGM), Universitat Autonòma de Barcelona, Cerdanyola del Vallès, Spain.; Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, Josep Trueta University Hospital, IDIBGI, Girona, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology-ICO, ONCOBELL-IDIBELL, L'Hospitalet de Llobregat, Spain.; Medical Sciences Department School of Medicine, University of Girona, Girona, Spain.; Ramon Y Cajal T; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Medical Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain.; Balmaña J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Academic Journal
Antolí A; Internal Medicine Department, Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Gómez-Vázquez JL; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Sierra-Fortuny A; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Bermudez-Carre C; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Framil M; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain; Immunology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Creus-Bachiller E; Hereditary Cancer Program, Catalan Institute of Oncology, ICO, Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Centre in Cancer Network (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Viana-Errasti J; Hereditary Cancer Program, Catalan Institute of Oncology, ICO, Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Rofes P; Hereditary Cancer Program, Catalan Institute of Oncology, ICO, Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Centre in Cancer Network (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Rocamora-Blanch G; Internal Medicine Department, Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Hidalgo-Peña L; Internal Medicine Department, Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; García-Serrano L; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Immunology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Rigo-Bonnin R; Clinical Laboratory Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology, ICO, Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Centre in Cancer Network (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Del Valle J; Hereditary Cancer Program, Catalan Institute of Oncology, ICO, Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Centre in Cancer Network (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Calatayud L; Microbiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Centre in Respiratory Diseases Network (CIBERES), Carlos III Health Institute, Madrid, Spain.; Morandeira F; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Immunology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Lázaro C; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain; Hereditary Cancer Program, Catalan Institute of Oncology, ICO, Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Biomedical Research Centre in Cancer Network (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Solanich X; Internal Medicine Department, Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain; Adult Primary Immunodeficiency Unit (UFIPA), Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Centre in Obesity and Nutrition Physiopathology Network (CIBEROBN), Carlos III Health Institute, Madrid, Spain. Electronic address: xsolanich@bellvitgehospital.cat.
Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-7035 (Electronic) Linking ISSN: 15216616 NLM ISO Abbreviation: Clin Immunol Subsets: MEDLINE
Academic Journal
Munté E; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Doctoral Programme in Biomedicine, University of Barcelona (UB), Casanova 143, 08036 Barcelona, Spain.; Roca C; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Doctoral Programme in Biomedicine, University of Barcelona (UB), Casanova 143, 08036 Barcelona, Spain.; Del Valle J; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain.; Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain.; Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain.; Gel B; Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.; Castellanos E; Clinical Genomics Research Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Camí de les Escoles s/n, Badalona, Barcelona, Spain.; Genetics Department, Germans Trias i Pujol University Hospital (HUGTiP), Can Ruti Campus, Carretera de Canyet s/n, 08916 Badalona, Barcelona, Spain.; Rivera B; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, McGill University, 5100 de Maisonneuve Blvd. West, Suite 720 Montreal, QC, Canada.; Cordero D; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PReTT), ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain.; Moreno V; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain.; Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Colorectal Cancer Group, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Clinical Sciences, Faculty of Medicine and Health Sciences, Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), Freixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain.; Moreno-Cabrera JM; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL-ONCOBELL, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Publisher: Oxford University Press Country of Publication: England NLM ID: 100912837 Publication Model: Print Cited Medium: Internet ISSN: 1477-4054 (Electronic) Linking ISSN: 14675463 NLM ISO Abbreviation: Brief Bioinform Subsets: MEDLINE
Academic Journal
Qian, FrankRookus, Matti A.Leslie, GoskaRisch, Harvey A.Greene, Mark H.Aalfs, Cora M.Adank, Muriel A.Adlard, JulianAgnarsson, Bjarni A.Ahmed, MunazaAittomäki, KristiinaAndrulis, Irene L.Arnold, NorbertArun, Banu K.Ausems, Margreet G. E. M.Azzollini, JacopoBarrowdale, DanielBarwell, JulianBenitez, JavierBiałkowska, KatarzynaBonadona, ValérieBorde, JulikaBorg, AkeBradbury, Angela R.Brunet, JoanBuys, Saundra S.Caldés, TrinidadCaligo, Maria A.Campbell, IanCarter, JonathanChiquette, JocelyneChung, Wendy K.Claes, Kathleen B. M.Collée, J. MargrietCollonge-Rame, Marie-AgnèsCouch, Fergus J.Daly, Mary B.Delnatte, CapucineDiez, OrlandDomchek, Susan M.Dorfling, Cecilia M.Eason, JacquelineEaston, Douglas F.Eeles, RosEngel, ChristophEvans, D. GarethFaivre, LaurenceFeliubadaló, LidiaForetova, LenkaFriedman, EitanFrost, DebraGanz, Patricia A.Garber, JudyGarcia-Barberan, VanesaGehrig, AndreaGlendon, GordGodwin, Andrew K.Gómez Garcia, Encarna B.Hamann, UteHauke, JanHopper, John L.Hulick, Peter J.Imyanitov, Evgeny N.Isaacs, ClaudineIzatt, LouiseJakubowska, AnnaJanavicius, RamunasJohn, Esther M.Karlan, Beth Y.Kets, Carolien M.Laitman, YaelLázaro, ConxiLeroux, DominiqueLester, JennyLesueur, FabienneLoud, Jennifer T.Lubiński, JanŁukomska, AlicjaMcGuffog, LesleyMebirouk, NouraMeijers-Heijboer, Hanne E. J.Meindl, AlfonsMiller, AustinMontagna, MarcoMooij, Thea M.Mouret-Fourme, EmmanuelleNathanson, Katherine L.Nehoray, BitaNeuhausen, Susan L.Nevanlinna, HeliNielsen, Finn C.Offit, KennethOlah, EdithOng, Kai-renOosterwijk, Jan C.Ottini, LauraParsons, Michael T.Peterlongo, PaoloPfeiler, GeorgPradhan, NishaRadice, PaoloRamus, Susan J.Rantala, JohannaRennert, GadRobson, MarkRodriguez, Gustavo C.Salani, RituScheuner, Maren T.Schmutzler, Rita K.Shah, Payal D.Side, Lucy E.Simard, JacquesSinger, Christian F.Steinemann, DorisStoppa-Lyonnet, DominiqueTan, Yen YenTeixeira, Manuel R.Terry, Mary BethThomassen, MadsTischkowitz, MarcTognazzo, SilviaToland, Amanda E.Tung, Nadinevan Asperen, Christi J.van Engelen, Klaartjevan Rensburg, Elizabeth J.Venat-Bouvet, LaurenceVierstraete, JeroenWagner, GabrielWalker, LisaWeitzel, Jeffrey N.Yannoukakos, DrakoulisKConFab InvestigatorsHEBON InvestigatorsGEMO Study CollaboratorsEMBRACE CollaboratorsAntoniou, Antonis C.Goldgar, David E.Olopade, Olufunmilayo I.Chenevix-Trench, GeorgiaRebbeck, Timothy R.Huo, Dezhengon behalf of CIMBA
British Journal of Cancer. 121(2):180-192
검색 결과 제한하기
제한된 항목
[검색어] Feliubadaló, L.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어